Filing Details
- Accession Number:
- 0001493152-19-015005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-03 18:42:49
- Reporting Period:
- 2019-10-01
- Accepted Time:
- 2019-10-03 18:42:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 868278 | Prophase Labs Inc. | PRPH | Pharmaceutical Preparations (2834) | 232577138 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645550 | Michael Jason Barr | 621 N. Shady Retreat Road Doylestown PA 18901 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0005 | Acquisiton | 2019-10-01 | 2,870 | $1.96 | 19,091 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- These shares were issued to the Reporting Person under the 2010 Directors' Equity Compensation Plan, as amended, in lieu of a cash payment for quarterly director fees.
Billionaire Hedge Funds
